CORINNA M OBANNON

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care GREENVILLE, SC NPI 1508045808

General Payments — all program years on this page

$1,141.23

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 62
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $319.46 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $319.4619

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $283.8210
2022 $255.1317
2023 $282.8216
2024 $319.4619

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1080584947 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $6.38 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080584949 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $19.57 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080584951 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $5.53 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086294068 Bayer Healthcare Pharmaceuticals Inc. $17.16 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087280813 Novartis Pharmaceuticals Corporation $16.20 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087280817 Novartis Pharmaceuticals Corporation $14.58 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087280823 Novartis Pharmaceuticals Corporation $19.00 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087280839 Novartis Pharmaceuticals Corporation $19.53 12/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101249905 E.R. Squibb & Sons, L.L.C. $14.85 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101249969 E.R. Squibb & Sons, L.L.C. $16.15 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115976136 Amgen Inc. $13.41 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118035741 Boehringer Ingelheim Pharmaceuticals, Inc. $13.55 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125098354 Abbott Laboratories $24.30 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125843371 Alnylam Pharmaceuticals Inc. $19.26 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125843457 Alnylam Pharmaceuticals Inc. $16.70 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129473440 Esperion Therapeutics, Inc. $20.65 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141717226 Merck Sharp & Dohme LLC $20.95 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141933903 Merck Sharp & Dohme LLC $16.76 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142296063 ABIOMED $24.93 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.